O’Hagan, E. et al. (2024) A cross-sectional survey of fixed-dose combination antihypertensive medicine prescribing in twenty-four countries, including qualitative insights. Global Heart, 9(1), 73. (doi: 10.5334/gh.1353) (PMID:39281000) (PMCID:PMC11396169)

Sherifali, D., da Silva, L. P., Dewan, P. , Cader, F. A., Dakhil, Z., Gyawali, B., Klassen, S., Yaseen, I. F., Jovkovic, M. and Khalid, S. (2024) Peer support for type 2 diabetes management in Low- and Middle-Income Countries (LMICs): A scoping review. Global Heart, 19(1), 20. (doi: 10.5334/gh.1299) (PMID:38404615) (PMCID:PMC10885823)

Wan, C., Read, S., Wu, H. , Lu, S., Zhang, X., Wild, S. H. and Liu, Y. (2022) Prediction of five-year cardiovascular disease risk in people with type 2 diabetes mellitus: derivation in Nanjing, China and external validation in Scotland, UK. Global Heart, 17(1), 46. (doi: 10.5334/gh.1131) (PMID:36051323) (PMCID:PMC9336685)

Cardona, M., Craig, L., Jones, M., Byambasuren, O., Obucina, M., Hattingh, L., Clark, J., Glasziou, P. and Hoffmann, T. (2022) Guideline adherence as an indicator of the extent of antithrombotic overuse and underuse: a systematic review. Global Heart, 17(1), 55. (doi: 10.5334/gh.1142) (PMID:36051325) (PMCID:PMC9374022)

Alam, S. I. et al. (2021) Secondary preventive care for cardiovascular diseases in Bangladesh: a national survey. Global Heart, 16(1), 31. (doi: 10.5334/gh.953) (PMID:34040944) (PMCID:PMC8086718)

Ferreira, J. P. et al. (2019) World Heart Federation Roadmap for heart failure. Global Heart, 14(3), pp. 197-214. (doi: 10.1016/j.gheart.2019.07.004) (PMID:31451235)

Amberbir, A. et al. (2019) Systematic review of hypertension and diabetes burden, risk factors, and interventions for prevention and control in Malawi. Global Heart, 14(2), pp. 109-118. (doi: 10.1016/j.gheart.2019.05.001) (PMID:31324364)